Heparin Market on Track for Moderate Growth, Reaching $12.2 Billion by 2032 (CAGR 3.00%)
The Heparin market is expected to reach USD 12.2 billion by 2032, growing at a modest 3% CAGR despite a small dip in 2024. The Heparin market is experiencing steady growth due to a rise in blood clot disorders and expanding applications beyond blood clot treatment. This growth is fueled by an aging population, increasing awareness of blood clot prevention, and the growing adoption of...
0 Commentaires 0 Parts 332 Vue 0 Aperçu
Commandité